Amicus Therapeutics, Inc. (FOLD) financial statements (2021 and earlier)

Company profile

Business Address 3675 MARKET STREET
PHILADELPHIA, PA 19104
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:483453504359330214
Cash and cash equivalents163143804918769
Short-term investments320310424310  
Other undisclosed cash, cash equivalents, and short-term investments    143145
Receivables47332291 
Inventory, net of allowances, customer advances and progress billings2014853 
Inventory2014853 
Other current assets     3
Other undisclosed current assets302017195(0)
Total current assets:579520551392340217
Noncurrent Assets
Operating lease, right-of-use asset2333
Property, plant and equipment4448119106
Intangible assets, net (including goodwill)221221221221684684
Goodwill198198198198198198
Intangible assets, net (excluding goodwill)23232323487487
Other noncurrent assets19287521
Total noncurrent assets:307330239235697692
TOTAL ASSETS:8878507906271,037908
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:9712081544132
Accounts payable1722781316
Accrued liabilities1316111485
Employee-related liabilities23272220106
Taxes payable117    
Interest and dividends payable 440  
Other undisclosed accounts payable and accrued liabilities33453712104
Debt 7    
Business combination, contingent consideration, liability9  85641
Other undisclosed current liabilities2416814 
Total current liabilities:130129867011174
Noncurrent Liabilities
Long-term debt and lease obligation4620332216415442
Long-term debt, excluding current maturities 15032216415442
Operating lease, liability4654
Liabilities, other than long-term debt28332326391410
Deferred compensation liability, classified    21
Deferred tax liabilities, net 6174176
Deferred income tax liabilities55
Other liabilities653221
Business combination, contingent consideration, liability17232017214233
Other undisclosed noncurrent liabilities397917   
Total noncurrent liabilities:470245361190545452
Total liabilities:600374447260656525
Stockholders' equity
Stockholders' equity attributable to parent286476343353360348
Common stock332211
Additional paid in capital2,3092,2271,7401,4011,120917
Accumulated other comprehensive income (loss)830(2)2(0)
Accumulated deficit(2,045)(1,769)(1,412)(1,064)(780)(580)
Warrants and rights outstanding12121316169
Total stockholders' equity:286476343353360348
Other undisclosed liabilities and equity   142035
TOTAL LIABILITIES AND EQUITY:8878507906271,037908

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues26118291375 
Revenue, net375 
Cost of revenue
(Cost of Goods and Services Sold)
(31)(22)(14)(6)(1) 
Gross profit:23016077314 
Operating expenses(477)(464)(406)(473)(186)(130)
Operating loss:(247)(304)(329)(442)(182)(130)
Nonoperating income (expense)28210(5)(0)
Investment income, nonoperating310104  
Foreign currency transaction loss, before tax  (3)   
Other nonoperating income (expense)(1)(3)(6)6(5)(0)
Interest and debt expense(30)(59)(22)(17)(5)(2)
Other undisclosed loss from continuing operations before equity method investments, income taxes     (0)
Loss from continuing operations before equity method investments, income taxes:(274)(356)(349)(449)(192)(132)
Other undisclosed loss from continuing operations before income taxes    (12) 
Loss from continuing operations before income taxes:(274)(356)(349)(449)(204)(132)
Income tax expense (benefit)(3)(0)01654 
Net loss available to common stockholders, diluted:(277)(356)(349)(284)(200)(132)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(277)(356)(349)(284)(200)(132)
Other comprehensive income (loss)0(0)  (1) 
Comprehensive loss:(277)(357)(349)(284)(201)(132)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent533(4)30
Comprehensive loss, net of tax, attributable to parent:(271)(354)(346)(288)(198)(132)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: